Concepedia

Zhenjiang Zhao

ZZ

Statistics

Publications

56

Citations

2K

H-Index

26

Active since

2004

Affiliations

East China University of Science and Technology(Current)

Chinese Academy of Sciences

Shanghai Institute of Materia Medica

Luoyang Orthopedic-Traumatological Hospital of Henan Province

Zhengzhou University

Zhenjiang Zhao is an author at East China University of Science and Technology specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2004–2025

56

Publications

56

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Rui Xiong, Leike Zhang, Shiliang Li et al. · Protein & Cell · 2020 · 209 citations · Full text

, , +16

Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways

Zhenjiang Zhao, Guoguo Jin, Yinghui Ge et al. · Inflammopharmacology · 2019 · 137 citations

, , +14

Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway

Dan Li, Gangcheng Wang, Guoguo Jin et al. · International Journal of Molecular Medicine · 2018 · 92 citations · Full text

, , +17

Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)

Huameng Li, Aiguo Liu, Zhenjiang Zhao et al. · Journal of Medicinal Chemistry · 2011 · 86 citations · Full text

, , +17

SHAFTS: A Hybrid Approach for 3D Molecular Similarity Calculation. 2. Prospective Case Study in the Discovery of Diverse p90 Ribosomal S6 Protein Kinase 2 Inhibitors To Suppress Cell Migration

Weiqiang Lü, Xiaofeng Liu, Xianwen Cao et al. · Journal of Medicinal Chemistry · 2011 · 79 citations · Full text

, , +17

1–5 of 56